Skip to main content

Inspection visit

Inspection

STUDEBAKER HEALTHCARE CENTERCMS #0564251 citation on this visit
1 citation recorded

Inspector’s narrative

What the inspector wrote

This survey cited 1 deficiency. The full statement and the facility’s plan of correction follow, verbatim from the federal record.

F 0761 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs. **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, and record review, the facility failed to ensure the facility had safe guards in place for their controlled drugs (a drug or other substance that is tightly controlled by the government because it may be abused or cause addiction) to prevent loss of and/or diversion (the illegal distribution or abuse of prescription drugs or their use for purposes not intended by the prescriber) of controlled drugs in the facility for two of three sampled residents (Residents 1 and 2), by failing to: 1. Ensure Resident 1 ' s Oxycodone Hydrochloride [a narcotic (a drug that works in the brain to dull the sense of pain) to relieve moderate to severe pain] 5 milligrams ([mg] a unit of measurement) was double locked in the Director of Nursing ' s Office and/or medication cart (a moveable piece of equipment used in healthcare facilities to store, transport, and dispense medicines, medical supplies, and emergency equipment). 2. Ensure the medication refrigerator was locked containing Lorazepam (medication for treatment of anxiety- schedule IV drug) was stored in the refrigerator per the facility ' s policy and procedure (P&P) titled Storage of Medications. These failures had the potential for theft, loss, drug diversion, and unauthorized consumption of medications. Findings: a. During a review of Resident 1 ' s admission Record (Face Sheet), the Face Sheet indicated Resident 1 was admitted to the facility on [DATE] with diagnosis including of fibromyalgia (a chronic condition characterized by widespread musculoskeletal pain, fatigue, and other symptoms). During a review of Resident 1 ' s Nursing Progress Notes dated 1/15/2025, the Nursing Progress Notes indicated Resident 1 was alert and oriented. During a review of Resident 1 ' s Individual Resident ' s Narcotic Record dated 1/2025, the Individual Resident ' s Narcotic Record indicated Resident 1 had two tablets (home medication brought in by Resident 1 upon admission to the facility) of Oxycodone 5 mg accounted for. The Resident ' s Individual Narcotic Record indicated Resident 1 received one tablet of Oxycodone 5 mg on 1/15/2025 at 8:30 p.m. b. During a review of Resident 2 ' s Face Sheet, the Face Sheet indicated Resident 2 was admitted (continued on next page) Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation. LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER REPRESENTATIVE'S SIGNATURE TITLE (X6) DATE FORM CMS-2567 (02/99) Previous Versions Obsolete Facility ID: If continuation sheet Page 1 of 2 Event ID: 056425 Printed: 05/15/2026 Form Approved OMB No. 0938-0391 Department of Health & Human Services Centers for Medicare & Medicaid Services STATEMENT OF DEFICIENCIES AND PLAN OF CORRECTION (X1) PROVIDER/SUPPLIER/CLIA IDENTIFICATION NUMBER: (X2) MULTIPLE CONSTRUCTION 056425 B. Wing A. Building (X3) DATE SURVEY COMPLETED 01/31/2025 NAME OF PROVIDER OR SUPPLIER STREET ADDRESS, CITY, STATE, ZIP CODE Studebaker Healthcare Center 13226 Studebaker Rd Norwalk, CA 90650 For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency. (X4) ID PREFIX TAG SUMMARY STATEMENT OF DEFICIENCIES (Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761 Level of Harm - Minimal harm or potential for actual harm Residents Affected - Some to the facility on [DATE] with diagnoses including of epilepsy (a brain disorder in which a person has repeated seizures [uncontrolled movement]). During a review of Resident 2 ' s Minimum Data Set (MDS – a federally mandated resident assessment tool) dated 1/17/2025, the MDS indicated Resident 2 ' s cognition was severely impaired and required substantial/maximal assistance (helper does more than half the effort) to complete Activities of Daily Living (ADLs – routine tasks/activities such as bathing, dressing and toileting a person performs daily). During a review of Resident 2 ' s Physician Order dated 8/8/2024, the Physician Order indicated Lorazepam solution 1 mg to be given intramuscularly ([IM] into a muscle) every six hours as needed for seizure episode. During a concurrent observation and interview on 1/31/2025 at 9:50 a.m. with the DON, in the station 2 medication room, Resident 1 ' s bottle of Oxycodone 5 mg was found in an unlocked drawer. The bottle of Oxycodone 5 mg was observed containing 1 tablet. The medication refrigerator ' s padlock (a portable or detachable lock) was observed lying on the top of the refrigerator. The DON stated the Resident 2 ' s Lorazepam should be locked in the medication refrigerator. During an interview on 1/31/2025 at 9:51 a.m. and subsequent interview at 1:45 p.m., the DON stated facility staff reported to her that Resident 1 had a bottle of Oxycodone in her purse when she was admitted and the bottle had two pills in the bottle. The DON stated the bottle of Oxycodone was stored in an unlocked drawer in the Station 2 medication room. The DON stated the Lorazepam solution should be locked in the refrigerator, and she could not provide an answer regarding what would happen to the Lorazepam solution if not properly secured. During a review of the facility ' s policy and procedure (P&P) titled Storage of Medications, dated 12/2023, the P&P indicated controlled medications scheduled II, III, IV are designated as such by a red controlled drug stamp and count sheet and are subject to special storage requirements. The P&P indicated the controlled medications must be stored in a double locked storage compartment except when given as regularly scheduled medications and part of the cycle medications (Schedule III and IV only). The P&P indicated schedule II medications must be double locked. FORM CMS-2567 (02/99) Previous Versions Obsolete Event ID: Facility ID: 056425 If continuation sheet Page 2 of 2

Reading this as a family member? Your long-term care ombudsman is a free advocate for residents and families.

Back to top

Citations

1 citation recorded*CMS

What do CMS severity letters mean?

Serious (G-L). Actual harm to a resident, or immediate jeopardy. Codes G through I indicate actual harm; J through L indicate immediate jeopardy to resident health or safety.

General (A-F). No actual harm found, or harm that is minimal. The facility must still submit a Plan of Correction. Most CMS citations land here.

Each letter combines severity with scope: how many residents the deficiency affected.

  • 0761GeneralS&S Epotential for harm

    F761 - Labeling of Drugs and Biologicals

    Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional principles; and all drugs and biologicals must be stored in locked compartments, separately locked, compartments for controlled drugs.

FAQ · About this visit

Common questions about this visit

What happened during the January 31, 2025 survey of STUDEBAKER HEALTHCARE CENTER?

This was a inspection survey of STUDEBAKER HEALTHCARE CENTER on January 31, 2025. The surveyor cited 1 deficiency, recorded on the federal Form 2567 statement of deficiencies.

Were any deficiencies cited at STUDEBAKER HEALTHCARE CENTER on January 31, 2025?

Yes, 1 deficiency was cited, each with a CMS Scope and Severity grade. The first was: "Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted professional princip..."

What type of survey was this?

This was a inspection survey conducted by state surveyors under federal Centers for Medicare & Medicaid Services (CMS) oversight. Findings are published on CMS Care Compare.

Share this reportEmail

Next steps

Concerned about a resident’s care?Find your local ombudsman through the Eldercare Locatoror file a complaint with your state survey agency.

Researching this visit professionally?Book a 15-minute calland we will walk through what we have on file.

Data from CMS Care Compare public records. Dataset last refreshed . If you believe any information is inaccurate, report it here.